This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Scripps Research Institute. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Sida Shao and Patent Innovation in Pulmonary Disease
Introduction
Sida Shao is an inventor associated with Scripps Research Institute in San Diego, California. Her patent work focuses on potential treatments for pulmonary diseases by promoting the proliferation of alveolar type 2 cells.
Latest Patents
Shao is named on one patent, Small Molecule Regulators of Alveolar Type 2 Cell Proliferation for the Treatment of Pulmonary Diseases. The disclosure describes compounds and pharmaceutical compositions that inhibit dipeptidyl peptidase IV (DPP4) and selectively promote the proliferation of alveolar type 2 cells (AEC2s). The proposed therapeutic applications include diseases associated with epithelial degeneration and maladaptive remodeling, such as idiopathic pulmonary fibrosis, acute respiratory distress syndrome, and infant respiratory distress syndromes.
Career Highlights
Shao’s listed patent reflects research aimed at translating insights into lung-cell biology into potential therapeutic approaches. The patent identifies Scripps Research Institute as her affiliated organization.
Collaborations
Michael J. Bollong is identified as a coworker associated with Shao’s research. Their connection reflects collaborative work in the research environment at Scripps Research Institute.
Conclusion
Sida Shao’s patent centers on DPP4-inhibiting compounds intended to support alveolar type 2 cell proliferation, highlighting a potential avenue for developing treatments for serious pulmonary diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile